<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>13</Volume>
				<Issue>7</Issue>
				<PubDate PubStatus="epublish">
					<Year>2012</Year>
					<Month>07</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>Association Between XPD Asp312Asn Polymorphism and Esophageal Cancer Susceptibility: A Meta-analysis</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>3299</FirstPage>
			<LastPage>3303</LastPage>
			<ELocationID EIdType="pii">26661</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: To investigate the association between xeroderma pigmentosum group D (XPD) Asp312Asnpolymorphism and esophageal cancer (EC) susceptibility by meta-analysis. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: We searched PubMed up toApril 9th, 2012, to identify relevant papers, and 8 published case-control studies including 2165 EC patients and3141 healthy controls were yielded. Odds ratios (ORs) with relevant 95% confidence intervals (CIs) were appliedto assess the association between XPD Asp312Asn polymorphism and EC susceptibility with the ComprehensiveMeta-Analysis software, version 2.2. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: Overall, the meta-analysis results suggested the XPD Asp312Asnpolymorphism to be significantly associated with EC susceptibility [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.20,95%CI=1.05-1.36, p=0.01; and Asp/Asn vs. Asp/Asp: OR= 1.15, 95%CI =1.01-1.31, p=0.04]. In the subgroupanalysis by ethnicity and cancer type, significantly associations were found for Caucasian populations [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.26, 95%CI =1.08-1.47, p&lt;0.001; Asp/Asn vs. Asp/Asp: OR=1.19, 95%CI =1.02-1.40, p=0.03] and esophageal squamous cell carcinoma [(Asn/Asn+Asp/Asn) vs. Asp/Asp: OR=1.19, 95%CI=1.01-1.41, p=0.04]. There was no heterogeneity and no publication bias existed. &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: This meta-analysisshows that the XPD Asp312Asn polymorphism may be a risk factor for developing EC, especially for Caucasianpopulations and esophageal squamous cell carcinoma.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">excision repair</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Polymorphism</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Esophageal Cancer</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Susceptibility</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">Meta-analysis</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_26661_ec4a64c913d535d64a319577251d70a3.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
